Significance of serum carcinoembryonic antigen in metastatic breast cancer patients: A prospective study
Open Access
- 24 June 2022
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Oncology
- Vol. 13 (6) , 529-539
Abstract
Significance of serum carcinoembryonic antigen in metastatic breast cancer patients: A prospective studyKeywords
This publication has 31 references indexed in Scilit:
- 1940 Correlation of preoperative Ki67 and CA15.3 levels with the outcome in early breast cancer. A multi institutional studyEuropean Journal of Cancer, 2015
- Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patientsClinica Chimica Acta, 2015
- Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast CancerPLOS ONE, 2015
- Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increaseBritish Journal of Cancer, 2015
- Association of CA 15-3 and CEA with clinicopathological parameters in patients with metastatic breast cancerMolecular and Clinical Oncology, 2014
- Follow-up of patients with early breast cancer: Is it time to rewrite the story?Critical Reviews in Oncology/Hematology, 2014
- Evaluation of a CLEIA automated assay system for the detection of a panel of tumor markersTumor Biology, 2013
- Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancerAnnals of Oncology, 2012
- Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcomeAnnals of Oncology, 2011
- Pre-treatment serum levels of tumour markers in metastatic breast cancer: a prospective assessment of their role in predicting response to therapy and survivalEuropean Journal of Surgical Oncology, 1995